RSNA ‘Radiology Advances’ Open-Access Journal Goes Live

Radiology Advances

Radiology Advances, the first exclusively open-access journal of the Radiological Society of North America (RSNA), published its first articles today.

Research

Radiology Advances will include a broad spectrum of high-quality international radiology research, freely available to readers without a subscription. Available exclusively online, the journal will offer continuous publication, featuring primarily original multidisciplinary research articles with a focus on emerging topics, cross-cutting and innovative research. Susanna I. Lee, M.D., Ph.D., is Radiology Advances editor.

Open-Access

“Radiology Advances is entirely open access, and all of the contents will be freely available from the moment of publication,” Dr. Lee said. “The journal will reflect the best and the breadth of the imaging sciences and all of the glorious innovations in technology and clinical practice that are currently underway.”

Radiology Advances provides timely dissemination of original research on emerging technologies and clinical innovations that are most likely to impact on the practice of radiology and patient outcomes and highlights technical innovations, translational research, clinical trials, and systematic reviews investigating breakthroughs in medical imaging.

“The speed and extent to which new knowledge spreads can be the essential feature in whether science improves health care,” Dr. Lee said. “However, peer and editorial review remains indispensable for maintaining the integrity of the scientific record. With Radiology Advances, our goal is to balance rapid, open publication with expert review.”

Published by RSNA in partnership with Oxford University Press

Radiology Advances provides radiologists, imaging scientists, trainees, physicists, and other medical imaging professionals with a global open access forum. The journal facilitates transparency and timeliness in the publication of rigorous and meaningful research to improve health and patient care.

“Radiology Advances is RSNA’s investment in the future of medical publishing,” Dr. Lee said. “We’ve come to expect no less from a society known for its strategic and comprehensive long-term planning.”

As an open-access journal, Radiology Advances offers both CC BY 4.0 and CC BY-NC-ND licenses and is compliant with funder mandates for open-access publishing. Peer-reviewed articles are published as advance articles prior to copyediting or typesetting to facilitate rapid dissemination. Once final, these articles will be continuously published in an open issue with the same digital object identifier (DOI).

Radiology Advances joins RSNA’s suite of peer-reviewed journals that includes the Society’s flagship journal, Radiology, education journal, RadioGraphics, and subspecialty journals, Radiology: Artificial Intelligence, Radiology: Cardiothoracic Imaging and Radiology: Imaging Cancer. To learn more about RSNA journals, visit RSNA.org/journals.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.